Literature DB >> 26561248

Enteral autonomy, cirrhosis, and long term transplant-free survival in pediatric intestinal failure patients.

Brenna S Fullerton1, Eric A Sparks1, Amber M Hall2, Christopher Duggan3, Tom Jaksic1, Biren P Modi4.   

Abstract

PURPOSE: Patient selection for transplant evaluation in pediatric intestinal failure is predicated on the ability to assess long-term transplant-free survival. In light of trends toward improved survival of intestinal failure patients in recent decades, we sought to determine if the presence of biopsy-proven hepatic cirrhosis or the eventual achievement of enteral autonomy were associated with transplant-free survival.
METHODS: After IRB approval, records of all pediatric intestinal failure patients (parenteral nutrition (PN) >90 days) treated at a single intestinal failure center from February 2002 to September 2014 were reviewed. Chi-squared, Mann-Whitney, and log-rank testing were performed as appropriate.
RESULTS: Of 313 patients, 174 eventually weaned off PN. Liver biopsies were available in 126 patients (most common indication was intestinal failure associated liver disease, IFALD), and 23 met histologic criteria for cirrhosis. Transplant-free survival for the whole cohort of 313 patients was 94.7% at 1 year and 89.2% at 5 years. Among patients with liver biopsies, transplant-free survival in cirrhotics vs. noncirrhotics was 95.5% vs. 94.1% at one year and 95.5% vs. 86.7% at 5 years (P=0.29). Transplant-free survival in patients who achieved enteral autonomy compared with patients who remained PN dependent was 98.2% vs. 90.3% at one year and 98.2% vs. 76.9% at 5 years (P<0.001). There was no association between cirrhosis and eventual enteral autonomy (P=0.88).
CONCLUSIONS: Achieving enteral autonomy was associated with improved transplant-free survival in pediatric intestinal failure patients. There was no association between histopathological diagnosis of cirrhosis and transplant-free survival in the cohort. These data suggest that automatic transplant referral may not be required for histopathological diagnosis of cirrhosis alone, and that ongoing efforts aimed at achievement of enteral autonomy remain paramount in pediatric intestinal failure.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; IFALD; Intestinal failure; Intestinal transplant; Multivisceral transplant; Parenteral nutrition

Mesh:

Year:  2015        PMID: 26561248      PMCID: PMC4713317          DOI: 10.1016/j.jpedsurg.2015.10.027

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  22 in total

1.  Developing trends in the intestinal transplant waitlist.

Authors:  K M Khan; C S Desai; M Mete; S Desale; R Girlanda; J Hawksworth; C Matsumoto; S Kaufman; T Fishbein
Journal:  Am J Transplant       Date:  2014-11-13       Impact factor: 8.086

2.  Refined Multidisciplinary Protocol-Based Approach to Short Bowel Syndrome Improves Outcomes.

Authors:  Laura Merras-Salmio; Mikko P Pakarinen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-07       Impact factor: 2.839

3.  Adverse effects of liver dysfunction and portal hypertension on intestinal adaptation in short bowel syndrome in children.

Authors:  Thomas R Weber; Martin S Keller
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

4.  Hepatic explant pathology of pediatric intestinal transplant recipients previously treated with omega-3 fatty acid lipid emulsion.

Authors:  Cal S Matsumoto; Stuart S Kaufman; Eddie R Island; Bhaskar Kallakury; Nada A Yazigi; Khalid M Khan; Thomas M Fishbein
Journal:  J Pediatr       Date:  2014-05-03       Impact factor: 4.406

5.  Enteral autonomy in pediatric short bowel syndrome: predictive factors one year after diagnosis.

Authors:  Farokh R Demehri; Lauren Stephens; Emma Herrman; Brady West; Ann Mehringer; Meghan A Arnold; Pamela I Brown; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2014-10-26       Impact factor: 2.545

6.  Aspartate aminotransferase to platelet ratio index correlates with hepatic cirrhosis but not with fibrosis in pediatric patients with intestinal failure.

Authors:  Juan J Díaz; Kathleen M Gura; Juliamna Roda; Antonio R Perez-Atayde; Christopher Duggan; Tom Jaksic; Clifford W Lo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

Review 7.  A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease.

Authors:  Paul W Wales; Nancy Allen; Patricia Worthington; Donald George; Charlene Compher; Daniel Teitelbaum
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-04-02       Impact factor: 4.016

8.  The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.

Authors:  Prathima Nandivada; Melissa I Chang; Alexis K Potemkin; Sarah J Carlson; Eileen Cowan; Alison A Oʼloughlin; Paul D Mitchell; Kathleen M Gura; Mark Puder
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

9.  Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium.

Authors:  Robert H Squires; Christopher Duggan; Daniel H Teitelbaum; Paul W Wales; Jane Balint; Robert Venick; Susan Rhee; Debra Sudan; David Mercer; J Andres Martinez; Beth A Carter; Jason Soden; Simon Horslen; Jeffrey A Rudolph; Samuel Kocoshis; Riccardo Superina; Sharon Lawlor; Tamara Haller; Marcia Kurs-Lasky; Steven H Belle
Journal:  J Pediatr       Date:  2012-05-11       Impact factor: 4.406

Review 10.  Non-invasive markers for hepatic fibrosis.

Authors:  Ancha Baranova; Priyanka Lal; Aybike Birerdinc; Zobair M Younossi
Journal:  BMC Gastroenterol       Date:  2011-08-17       Impact factor: 3.067

View more
  10 in total

Review 1.  New Insights Into Intestinal Failure-Associated Liver Disease in Children.

Authors:  Racha T Khalaf; Ronald J Sokol
Journal:  Hepatology       Date:  2020-03-18       Impact factor: 17.425

2.  Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.

Authors:  Caroline Wang; Robert S Venick; Stephen B Shew; James C Y Dunn; Laurie Reyen; Rong Gou; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-11-08       Impact factor: 4.016

Review 3.  Redefining short bowel syndrome in the 21st century.

Authors:  Valeria C Cohran; Joshua D Prozialeck; Conrad R Cole
Journal:  Pediatr Res       Date:  2016-12-20       Impact factor: 3.756

Review 4.  Approach to Intestinal Failure in Children.

Authors:  Danielle Wendel; Conrad R Cole; Valeria C Cohran
Journal:  Curr Gastroenterol Rep       Date:  2021-04-15

5.  Efficient achievement of enteral autonomy facilitates resolution of liver injury in necrotizing enterocolitis induced short bowel syndrome.

Authors:  Annika Mutanen; Ville Pöntinen; Riikka Gunnar; Laura Merras-Salmio; Mikko P Pakarinen
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

6.  Short Bowel Syndrome.

Authors:  Baddr A Shakhsheer; Brad W Warner
Journal:  Curr Treat Options Pediatr       Date:  2019-10-11

Review 7.  An overview of the current management of short-bowel syndrome in pediatric patients.

Authors:  Mitsuru Muto; Tatsuru Kaji; Shun Onishi; Keisuke Yano; Waka Yamada; Satoshi Ieiri
Journal:  Surg Today       Date:  2021-01-19       Impact factor: 2.549

Review 8.  Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.

Authors:  Lorenzo Norsa; Emanuele Nicastro; Angelo Di Giorgio; Florence Lacaille; Lorenzo D'Antiga
Journal:  Nutrients       Date:  2018-05-24       Impact factor: 5.717

9.  Clinical outcomes in pediatric intestinal failure: a meta-analysis and meta-regression.

Authors:  Aureliane Chantal Stania Pierret; James Thomas Wilkinson; Matthias Zilbauer; Jake Peter Mann
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

10.  Prediction of intestinal failure from necrotizing enterocolitis following surgery: A multicenter retrospective review.

Authors:  Huan Wang; Yan Wang; Chun Deng; Lei Li; Chunbao Guo
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.